Evidence map›Paper›PMID 28085486›Full record

ArticleAmerican journal of respiratory and critical care medicine2017

Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.

Philip L Molyneaux, Saffron A G Willis-Owen, Michael J Cox, Phillip James, Steven Cowman, Michael Loebinger, Andrew Blanchard, Lindsay M Edwards, Carmel Stock, Cécile Daccord and 5 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 2 pooled it
20.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 2 syntheses or guidelines pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Effect of CTMP1 gene on pulmonary fibrosis.Toxicological research · 2025
    Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Philip L Molyneaux1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Saffron A G Willis-Owen1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Michael J Cox1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Phillip James1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Steven Cowman1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Michael Loebinger1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Andrew Blanchard3 Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom.
Lindsay M Edwards3 Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom.
Carmel Stock1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Cécile Daccord1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Elisabetta A Renzoni1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Athol U Wells2 Royal Brompton Hospital, London, United Kingdom; and.
Miriam F Moffatt1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
William O C Cookson1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Toby M Maher1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Royal Brompton Hospital · GBImperial College London · GBGlaxoSmithKline (United Kingdom) · GB

Funding

Mechanisms of Familial Pulmonary FibrosisP01HL092870 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLACKWELL, TIMOTHY S. · 2010 to 2020
$21.6M
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)R01HL097163 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FINGERLIN, TASHA E., SCHWARTZ, DAVID ALBERT · 2009 to 2018
$16.4M
HSRD VA CDA 13-017Medical Research Council G1000758NHLBI NIH HHS P01 HL092870NHLBI NIH HHS R01 HL097163Wellcome Trust
6 · The paper itself

Abstract

rationaleChanges in the respiratory microbiome are associated with disease progression in idiopathic pulmonary fibrosis (IPF). The role of the host response to the respiratory microbiome remains unknown.

objectivesTo explore the host-microbial interactions in IPF.

methodsSixty patients diagnosed with IPF were prospectively enrolled together with 20 matched control subjects. Subjects underwent bronchoalveolar lavage (BAL), and peripheral whole blood was collected into PAXgene tubes for all subjects at baseline. For subjects with IPF, additional samples were taken at 1, 3, and 6 months and (if alive) 1 year. Gene expression profiles were generated using Affymetrix Human Gene 1.1 ST arrays. MEASUREMENTS AND MAIN

resultsBy network analysis of gene expression data, we identified two gene modules that strongly associated with a diagnosis of IPF, BAL bacterial burden (determined by 16S quantitative polymerase chain reaction), and specific microbial operational taxonomic units, as well as with lavage and peripheral blood neutrophilia. Genes within these modules that are involved in the host defense response include NLRC4, PGLYRP1, MMP9, and DEFA4. The modules also contain two genes encoding specific antimicrobial peptides (SLPI and CAMP). Many of these particular transcripts were associated with survival and showed longitudinal overexpression in subjects experiencing disease progression, further strengthening the relationship of the transcripts with disease.

conclusionsIntegrated analysis of the host transcriptome and microbial signatures demonstrated an apparent host response to the presence of an altered or more abundant microbiome. These responses remained elevated in longitudinal follow-up, suggesting that the bacterial communities of the lower airways may act as persistent stimuli for repetitive alveolar injury in IPF.

Indexed as

Host-Pathogen InteractionsAgedBronchoalveolar Lavage FluidFemaleFollow-Up StudiesHumansIdiopathic Pulmonary FibrosisMaleMicrobiotaProspective StudiesTranscriptomeacute lung injuryexpressionidiopathic pulmonary fibrosismicrobiomeusual interstitial pneumonia

Identifiers

PMID28085486
PMCPMC5476909
OpenAlexW2577072690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.